Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.53164759 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.53164759 |
3 | exogenous drug catabolic process (GO:0042738) | 7.23736472 |
4 | L-phenylalanine metabolic process (GO:0006558) | 7.19524668 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.19524668 |
6 | epoxygenase P450 pathway (GO:0019373) | 6.90074834 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 6.73019843 |
8 | omega-hydroxylase P450 pathway (GO:0097267) | 6.67171218 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.44417164 |
10 | tryptophan catabolic process (GO:0006569) | 6.09740466 |
11 | indole-containing compound catabolic process (GO:0042436) | 6.09740466 |
12 | indolalkylamine catabolic process (GO:0046218) | 6.09740466 |
13 | kynurenine metabolic process (GO:0070189) | 5.98779125 |
14 | negative regulation of fibrinolysis (GO:0051918) | 5.93839037 |
15 | bile acid biosynthetic process (GO:0006699) | 5.88072408 |
16 | glyoxylate metabolic process (GO:0046487) | 5.84817282 |
17 | tryptophan metabolic process (GO:0006568) | 5.73903680 |
18 | regulation of fibrinolysis (GO:0051917) | 5.72650309 |
19 | urea cycle (GO:0000050) | 5.70940143 |
20 | urea metabolic process (GO:0019627) | 5.70940143 |
21 | complement activation, alternative pathway (GO:0006957) | 5.68753022 |
22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.65825108 |
23 | * regulation of protein activation cascade (GO:2000257) | 5.57988979 |
24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.55431687 |
25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.55098127 |
26 | protein carboxylation (GO:0018214) | 5.55098127 |
27 | * positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.52684451 |
28 | uronic acid metabolic process (GO:0006063) | 5.48243616 |
29 | regulation of complement activation (GO:0030449) | 5.36951240 |
30 | cysteine metabolic process (GO:0006534) | 5.26854322 |
31 | regulation of humoral immune response (GO:0002920) | 5.24693931 |
32 | nitrogen cycle metabolic process (GO:0071941) | 5.23905976 |
33 | sulfur amino acid catabolic process (GO:0000098) | 5.19482094 |
34 | serine family amino acid catabolic process (GO:0009071) | 5.06201057 |
35 | reverse cholesterol transport (GO:0043691) | 5.02614775 |
36 | bile acid metabolic process (GO:0008206) | 5.02607342 |
37 | intestinal cholesterol absorption (GO:0030299) | 4.98381599 |
38 | regulation of cholesterol esterification (GO:0010872) | 4.96363543 |
39 | regulation of triglyceride catabolic process (GO:0010896) | 4.94549555 |
40 | macromolecular complex remodeling (GO:0034367) | 4.91903815 |
41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.91903815 |
42 | protein-lipid complex remodeling (GO:0034368) | 4.91903815 |
43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.91741057 |
44 | aromatic amino acid family metabolic process (GO:0009072) | 4.88399760 |
45 | drug metabolic process (GO:0017144) | 4.83641158 |
46 | tyrosine metabolic process (GO:0006570) | 4.75615910 |
47 | phospholipid efflux (GO:0033700) | 4.70162723 |
48 | homocysteine metabolic process (GO:0050667) | 4.70140565 |
49 | acylglycerol homeostasis (GO:0055090) | 4.69627207 |
50 | triglyceride homeostasis (GO:0070328) | 4.69627207 |
51 | alpha-amino acid catabolic process (GO:1901606) | 4.57780310 |
52 | lysine metabolic process (GO:0006553) | 4.55644141 |
53 | lysine catabolic process (GO:0006554) | 4.55644141 |
54 | amino-acid betaine metabolic process (GO:0006577) | 4.52780470 |
55 | negative regulation of sterol transport (GO:0032372) | 4.51114903 |
56 | negative regulation of cholesterol transport (GO:0032375) | 4.51114903 |
57 | plasma lipoprotein particle clearance (GO:0034381) | 4.48218950 |
58 | regulation of apoptotic cell clearance (GO:2000425) | 4.46456782 |
59 | oxidative demethylation (GO:0070989) | 4.39551458 |
60 | glycine metabolic process (GO:0006544) | 4.36191692 |
61 | cholesterol efflux (GO:0033344) | 4.36103325 |
62 | coenzyme catabolic process (GO:0009109) | 4.34604253 |
63 | bile acid and bile salt transport (GO:0015721) | 4.34378256 |
64 | cellular ketone body metabolic process (GO:0046950) | 4.33374925 |
65 | indolalkylamine metabolic process (GO:0006586) | 4.31294052 |
66 | * negative regulation of hemostasis (GO:1900047) | 4.30827702 |
67 | * negative regulation of blood coagulation (GO:0030195) | 4.30827702 |
68 | imidazole-containing compound metabolic process (GO:0052803) | 4.30789322 |
69 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.30546950 |
70 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.30546950 |
71 | protein-lipid complex subunit organization (GO:0071825) | 4.23775676 |
72 | glutamate metabolic process (GO:0006536) | 4.23222682 |
73 | fibrinolysis (GO:0042730) | 4.22110807 |
74 | amine catabolic process (GO:0009310) | 4.20214540 |
75 | cellular biogenic amine catabolic process (GO:0042402) | 4.20214540 |
76 | ethanol metabolic process (GO:0006067) | 4.19549435 |
77 | cellular amino acid catabolic process (GO:0009063) | 4.19078567 |
78 | plasma lipoprotein particle assembly (GO:0034377) | 4.15579672 |
79 | serine family amino acid metabolic process (GO:0009069) | 4.12481278 |
80 | positive regulation of blood coagulation (GO:0030194) | 4.07466046 |
81 | positive regulation of hemostasis (GO:1900048) | 4.07466046 |
82 | blood coagulation, intrinsic pathway (GO:0007597) | 4.07295997 |
83 | acute-phase response (GO:0006953) | 4.07250831 |
84 | benzene-containing compound metabolic process (GO:0042537) | 4.06421490 |
85 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.05363914 |
86 | low-density lipoprotein particle remodeling (GO:0034374) | 4.05176547 |
87 | cellular glucuronidation (GO:0052695) | 4.04376579 |
88 | cellular modified amino acid catabolic process (GO:0042219) | 4.02556834 |
89 | arginine metabolic process (GO:0006525) | 3.99780602 |
90 | complement activation, classical pathway (GO:0006958) | 3.99133224 |
91 | serine family amino acid biosynthetic process (GO:0009070) | 3.98698354 |
92 | negative regulation of complement activation (GO:0045916) | 3.98348305 |
93 | * negative regulation of protein activation cascade (GO:2000258) | 3.98348305 |
94 | aldehyde catabolic process (GO:0046185) | 3.94758299 |
95 | * negative regulation of coagulation (GO:0050819) | 3.93195686 |
96 | complement activation (GO:0006956) | 3.93162183 |
97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.92058663 |
98 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.92058663 |
99 | * negative regulation of wound healing (GO:0061045) | 3.91803215 |
100 | ethanol oxidation (GO:0006069) | 3.91751512 |
101 | opsonization (GO:0008228) | 3.85512551 |
102 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.84402214 |
103 | * protein activation cascade (GO:0072376) | 3.83983981 |
104 | phospholipid homeostasis (GO:0055091) | 3.83757723 |
105 | acute inflammatory response (GO:0002526) | 3.82942452 |
106 | cofactor catabolic process (GO:0051187) | 3.80877055 |
107 | positive regulation of lipid catabolic process (GO:0050996) | 3.79769708 |
108 | drug catabolic process (GO:0042737) | 3.79767062 |
109 | cholesterol homeostasis (GO:0042632) | 3.76819609 |
110 | cytolysis (GO:0019835) | 3.76617752 |
111 | plasma lipoprotein particle organization (GO:0071827) | 3.76229801 |
112 | positive regulation of coagulation (GO:0050820) | 3.76225815 |
113 | ketone body metabolic process (GO:1902224) | 3.74809744 |
114 | negative regulation of lipase activity (GO:0060192) | 3.74654325 |
115 | regulation of cholesterol homeostasis (GO:2000188) | 3.73973082 |
116 | heme transport (GO:0015886) | 3.72760479 |
117 | protein-lipid complex assembly (GO:0065005) | 3.72038211 |
118 | phenylpropanoid metabolic process (GO:0009698) | 3.71284187 |
119 | flavonoid metabolic process (GO:0009812) | 3.70849201 |
120 | sterol homeostasis (GO:0055092) | 3.70623545 |
121 | regulation of bile acid biosynthetic process (GO:0070857) | 3.66445828 |
122 | carboxylic acid catabolic process (GO:0046395) | 3.65376186 |
123 | organic acid catabolic process (GO:0016054) | 3.65376186 |
124 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.62336237 |
125 | regulation of plasminogen activation (GO:0010755) | 3.61456481 |
126 | lipoprotein metabolic process (GO:0042157) | 3.61128415 |
127 | acetyl-CoA metabolic process (GO:0006084) | 3.60990794 |
128 | doxorubicin metabolic process (GO:0044598) | 3.60651100 |
129 | daunorubicin metabolic process (GO:0044597) | 3.60651100 |
130 | polyketide metabolic process (GO:0030638) | 3.60651100 |
131 | glucuronate metabolic process (GO:0019585) | 3.57799281 |
132 | regulation of acute inflammatory response (GO:0002673) | 3.52453085 |
133 | sterol transport (GO:0015918) | 3.48526117 |
134 | cholesterol transport (GO:0030301) | 3.48526117 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.31565171 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.13871139 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.02361695 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.46474356 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.30182623 |
6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.19431167 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.79439619 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.15082267 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.13342799 |
10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03909093 |
11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.1314380 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97921187 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91842041 |
14 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62828316 |
15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56952804 |
16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.52995987 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51588314 |
18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43371751 |
19 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40714667 |
20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30041445 |
21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.24124688 |
22 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.20907809 |
23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20219528 |
24 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19027396 |
25 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.07321497 |
26 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.06123812 |
27 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.04695386 |
28 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02332111 |
29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01798347 |
30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97043404 |
31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95317419 |
32 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.93310496 |
33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90859870 |
34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90186703 |
35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87359588 |
36 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82908778 |
37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81934009 |
38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80502019 |
39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79712160 |
40 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.79350838 |
41 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77483849 |
42 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75878320 |
43 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.73082882 |
44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.72987992 |
45 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72705121 |
46 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72637248 |
47 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72163593 |
48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71009403 |
49 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.70582480 |
50 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.69845711 |
51 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69771263 |
52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.68990740 |
53 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68333501 |
54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.67951123 |
55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67364855 |
56 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.66003119 |
57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63165733 |
58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63165733 |
59 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62531314 |
60 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61323449 |
61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60723477 |
62 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.60004400 |
63 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.59064020 |
64 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58997156 |
65 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.57364780 |
66 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57264278 |
67 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.56991463 |
68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.56088560 |
69 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.56061451 |
70 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.55975931 |
71 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55740737 |
72 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.54987567 |
73 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.54909970 |
74 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.54777531 |
75 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.54706774 |
76 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53412727 |
77 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53052641 |
78 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.52668929 |
79 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51485848 |
80 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.51412805 |
81 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50952415 |
82 | TP53_16413492_ChIP-PET_HCT116_Human | 0.50823784 |
83 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.50511106 |
84 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.50364558 |
85 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.50264314 |
86 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.49928871 |
87 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49768637 |
88 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49757323 |
89 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.49352119 |
90 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.49230857 |
91 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.48650033 |
92 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.48187329 |
93 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.47853324 |
94 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.46782070 |
95 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46764413 |
96 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.46161244 |
97 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.45788719 |
98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.45615686 |
99 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45246829 |
100 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.45021518 |
101 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.44985979 |
102 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.44613058 |
103 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44258679 |
104 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.43947861 |
105 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43823434 |
106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43761503 |
107 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.42590739 |
108 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42370270 |
109 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42295732 |
110 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41762815 |
111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.41559769 |
112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41284252 |
113 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.41196145 |
114 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40248418 |
115 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39952978 |
116 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.39722226 |
117 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38646939 |
118 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.38350033 |
119 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.38257116 |
120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.37761667 |
121 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37245471 |
122 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36045222 |
123 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.35337227 |
124 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.35313395 |
125 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.34205858 |
126 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.33698625 |
127 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.33347925 |
128 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.33268076 |
129 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.32899736 |
130 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.32842421 |
131 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.32437949 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.16011589 |
2 | MP0005360_urolithiasis | 7.49758653 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.42538986 |
4 | MP0005365_abnormal_bile_salt | 6.11302373 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.96456999 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.24012919 |
7 | MP0003252_abnormal_bile_duct | 3.88627315 |
8 | MP0010329_abnormal_lipoprotein_level | 3.64521118 |
9 | MP0009840_abnormal_foam_cell | 3.32641008 |
10 | MP0005083_abnormal_biliary_tract | 3.19850582 |
11 | MP0003195_calcinosis | 2.83713399 |
12 | MP0005332_abnormal_amino_acid | 2.73478191 |
13 | MP0003191_abnormal_cellular_cholesterol | 2.66435208 |
14 | MP0001666_abnormal_nutrient_absorption | 2.59136554 |
15 | MP0000609_abnormal_liver_physiology | 2.21053710 |
16 | MP0004019_abnormal_vitamin_homeostasis | 2.12185049 |
17 | MP0002118_abnormal_lipid_homeostasis | 2.10801840 |
18 | MP0002138_abnormal_hepatobiliary_system | 2.00780756 |
19 | MP0003868_abnormal_feces_composition | 1.85582337 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82623755 |
21 | MP0001764_abnormal_homeostasis | 1.62668330 |
22 | MP0009697_abnormal_copulation | 1.59254894 |
23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57133509 |
24 | MP0003011_delayed_dark_adaptation | 1.48757578 |
25 | MP0003656_abnormal_erythrocyte_physiolo | 1.32620510 |
26 | MP0005451_abnormal_body_composition | 1.32488026 |
27 | MP0001915_intracranial_hemorrhage | 1.24835054 |
28 | MP0009643_abnormal_urine_homeostasis | 1.23272748 |
29 | MP0003122_maternal_imprinting | 1.22266096 |
30 | MP0000604_amyloidosis | 1.21592658 |
31 | MP0003186_abnormal_redox_activity | 1.21450564 |
32 | MP0003705_abnormal_hypodermis_morpholog | 1.21097619 |
33 | * MP0000598_abnormal_liver_morphology | 1.18131879 |
34 | MP0002254_reproductive_system_inflammat | 1.14803760 |
35 | MP0005647_abnormal_sex_gland | 1.14459472 |
36 | MP0009764_decreased_sensitivity_to | 1.11317787 |
37 | MP0010368_abnormal_lymphatic_system | 1.10079260 |
38 | MP0009763_increased_sensitivity_to | 1.08855325 |
39 | MP0005636_abnormal_mineral_homeostasis | 0.97633014 |
40 | MP0005058_abnormal_lysosome_morphology | 0.97118798 |
41 | * MP0008469_abnormal_protein_level | 0.90922652 |
42 | * MP0009642_abnormal_blood_homeostasis | 0.88447719 |
43 | MP0000566_synostosis | 0.86731727 |
44 | MP0005670_abnormal_white_adipose | 0.86450596 |
45 | MP0004272_abnormal_basement_membrane | 0.85787487 |
46 | MP0005408_hypopigmentation | 0.83458157 |
47 | MP0002089_abnormal_postnatal_growth/wei | 0.82041066 |
48 | MP0009765_abnormal_xenobiotic_induced | 0.81275474 |
49 | MP0005084_abnormal_gallbladder_morpholo | 0.80921745 |
50 | MP0005376_homeostasis/metabolism_phenot | 0.79579344 |
51 | MP0005220_abnormal_exocrine_pancreas | 0.79504280 |
52 | MP0002078_abnormal_glucose_homeostasis | 0.77479676 |
53 | MP0006036_abnormal_mitochondrial_physio | 0.77278612 |
54 | MP0002971_abnormal_brown_adipose | 0.75634602 |
55 | MP0001661_extended_life_span | 0.73003985 |
56 | MP0002282_abnormal_trachea_morphology | 0.72687005 |
57 | MP0002876_abnormal_thyroid_physiology | 0.71446122 |
58 | MP0003690_abnormal_glial_cell | 0.71335775 |
59 | MP0009053_abnormal_anal_canal | 0.68959599 |
60 | MP0005334_abnormal_fat_pad | 0.68813349 |
61 | MP0003879_abnormal_hair_cell | 0.67287266 |
62 | MP0004130_abnormal_muscle_cell | 0.66233667 |
63 | MP0005535_abnormal_body_temperature | 0.66055304 |
64 | MP0000639_abnormal_adrenal_gland | 0.63299099 |
65 | MP0003329_amyloid_beta_deposits | 0.62852204 |
66 | MP0005266_abnormal_metabolism | 0.62212253 |
67 | MP0001756_abnormal_urination | 0.58103312 |
68 | MP0003123_paternal_imprinting | 0.56352077 |
69 | MP0005448_abnormal_energy_balance | 0.55341877 |
70 | MP0006035_abnormal_mitochondrial_morpho | 0.55190591 |
71 | MP0005395_other_phenotype | 0.53564722 |
72 | MP0005409_darkened_coat_color | 0.52807595 |
73 | MP0003436_decreased_susceptibility_to | 0.52605912 |
74 | MP0003724_increased_susceptibility_to | 0.51624362 |
75 | MP0005187_abnormal_penis_morphology | 0.51494788 |
76 | * MP0005464_abnormal_platelet_physiology | 0.49015288 |
77 | MP0002136_abnormal_kidney_physiology | 0.47359659 |
78 | MP0003632_abnormal_nervous_system | 0.46808186 |
79 | MP0002928_abnormal_bile_duct | 0.46706968 |
80 | MP0003638_abnormal_response/metabolism_ | 0.46244747 |
81 | MP0008873_increased_physiological_sensi | 0.45378720 |
82 | MP0003718_maternal_effect | 0.44778704 |
83 | MP0000579_abnormal_nail_morphology | 0.44415862 |
84 | MP0009384_cardiac_valve_regurgitation | 0.43820745 |
85 | MP0003075_altered_response_to | 0.43648260 |
86 | MP0008874_decreased_physiological_sensi | 0.43443018 |
87 | MP0003941_abnormal_skin_development | 0.43241909 |
88 | MP0002822_catalepsy | 0.43019676 |
89 | MP0005166_decreased_susceptibility_to | 0.42904239 |
90 | MP0003172_abnormal_lysosome_physiology | 0.42397172 |
91 | MP0003953_abnormal_hormone_level | 0.40053693 |
92 | MP0005666_abnormal_adipose_tissue | 0.38531721 |
93 | MP0002249_abnormal_larynx_morphology | 0.38421240 |
94 | MP0002837_dystrophic_cardiac_calcinosis | 0.37741096 |
95 | MP0005248_abnormal_Harderian_gland | 0.37727263 |
96 | MP0004782_abnormal_surfactant_physiolog | 0.37462815 |
97 | MP0004381_abnormal_hair_follicle | 0.36545632 |
98 | MP0001986_abnormal_taste_sensitivity | 0.36454090 |
99 | MP0009780_abnormal_chondrocyte_physiolo | 0.35290171 |
100 | MP0002796_impaired_skin_barrier | 0.34657812 |
101 | MP0004883_abnormal_blood_vessel | 0.34238722 |
102 | MP0000249_abnormal_blood_vessel | 0.34115726 |
103 | * MP0005023_abnormal_wound_healing | 0.34017306 |
104 | MP0008872_abnormal_physiological_respon | 0.33187410 |
105 | MP0002168_other_aberrant_phenotype | 0.32891476 |
106 | MP0009115_abnormal_fat_cell | 0.32804524 |
107 | MP0009672_abnormal_birth_weight | 0.32791521 |
108 | MP0006082_CNS_inflammation | 0.32074882 |
109 | MP0001881_abnormal_mammary_gland | 0.31849748 |
110 | MP0006054_spinal_hemorrhage | 0.31708742 |
111 | MP0001243_abnormal_dermal_layer | 0.31361154 |
112 | MP0002970_abnormal_white_adipose | 0.31316475 |
113 | MP0001845_abnormal_inflammatory_respons | 0.30988007 |
114 | MP0004264_abnormal_extraembryonic_tissu | 0.30797294 |
115 | MP0005164_abnormal_response_to | 0.29893190 |
116 | MP0001853_heart_inflammation | 0.29695071 |
117 | MP0000230_abnormal_systemic_arterial | 0.29402824 |
118 | * MP0002128_abnormal_blood_circulation | 0.28712309 |
119 | MP0000371_diluted_coat_color | 0.28520951 |
120 | MP0005167_abnormal_blood-brain_barrier | 0.28152876 |
121 | MP0002132_abnormal_respiratory_system | 0.27849537 |
122 | MP0001324_abnormal_eye_pigmentation | 0.27580240 |
123 | MP0000427_abnormal_hair_cycle | 0.27580200 |
124 | MP0002909_abnormal_adrenal_gland | 0.27529177 |
125 | MP0002135_abnormal_kidney_morphology | 0.27388194 |
126 | MP0009785_altered_susceptibility_to | 0.25887349 |
127 | MP0000467_abnormal_esophagus_morphology | 0.25730078 |
128 | MP0003566_abnormal_cell_adhesion | 0.25441416 |
129 | MP0000858_altered_metastatic_potential | 0.24697367 |
130 | MP0002697_abnormal_eye_size | 0.22905447 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.58130445 |
2 | Intrahepatic cholestasis (HP:0001406) | 7.29410009 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.26867281 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 6.85348213 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.64392875 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.43461049 |
7 | Xanthomatosis (HP:0000991) | 6.32696355 |
8 | Complement deficiency (HP:0004431) | 5.84905431 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.61290848 |
10 | Joint hemorrhage (HP:0005261) | 5.04313074 |
11 | Hypolipoproteinemia (HP:0010981) | 4.90778938 |
12 | * Abnormality of the common coagulation pathway (HP:0010990) | 4.62765593 |
13 | Epidermoid cyst (HP:0200040) | 4.55493989 |
14 | Hyperammonemia (HP:0001987) | 4.55298505 |
15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.48487690 |
16 | Hypoalphalipoproteinemia (HP:0003233) | 4.37741455 |
17 | Hyperglycinemia (HP:0002154) | 4.33224075 |
18 | Abnormality of complement system (HP:0005339) | 4.27920208 |
19 | Abnormality of methionine metabolism (HP:0010901) | 4.25029766 |
20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.21789206 |
21 | Ketosis (HP:0001946) | 4.15927730 |
22 | Fat malabsorption (HP:0002630) | 4.15388751 |
23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.11865211 |
24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.09713475 |
25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.95049782 |
26 | Hypoglycemic coma (HP:0001325) | 3.86240992 |
27 | Abnormality of glycine metabolism (HP:0010895) | 3.79767807 |
28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.79767807 |
29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.77085041 |
30 | Hyperglycinuria (HP:0003108) | 3.75960159 |
31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.74416233 |
32 | Hypercholesterolemia (HP:0003124) | 3.60975222 |
33 | Hyperbilirubinemia (HP:0002904) | 3.30991581 |
34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.22699905 |
35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.20350527 |
36 | Steatorrhea (HP:0002570) | 3.08285698 |
37 | Myocardial infarction (HP:0001658) | 3.06191130 |
38 | * Spontaneous abortion (HP:0005268) | 3.05533865 |
39 | Hypochromic microcytic anemia (HP:0004840) | 3.04771840 |
40 | Hepatocellular carcinoma (HP:0001402) | 3.01095153 |
41 | Abnormality of serum amino acid levels (HP:0003112) | 2.99857134 |
42 | Abnormality of nucleobase metabolism (HP:0010932) | 2.98957163 |
43 | Delayed CNS myelination (HP:0002188) | 2.95773528 |
44 | Systemic lupus erythematosus (HP:0002725) | 2.94392745 |
45 | Ketoacidosis (HP:0001993) | 2.94088934 |
46 | Osteomalacia (HP:0002749) | 2.85694869 |
47 | Skin nodule (HP:0200036) | 2.82147506 |
48 | Glomerulonephritis (HP:0000099) | 2.75229229 |
49 | Acanthocytosis (HP:0001927) | 2.70095465 |
50 | Purpura (HP:0000979) | 2.67706306 |
51 | Metabolic acidosis (HP:0001942) | 2.67213746 |
52 | Abnormality of purine metabolism (HP:0004352) | 2.59893224 |
53 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.54922356 |
54 | Hypoglycemic seizures (HP:0002173) | 2.54814351 |
55 | Vascular calcification (HP:0004934) | 2.54770071 |
56 | Lethargy (HP:0001254) | 2.53274879 |
57 | Spastic diplegia (HP:0001264) | 2.48612637 |
58 | Abnormal gallbladder morphology (HP:0012437) | 2.46961897 |
59 | Dicarboxylic aciduria (HP:0003215) | 2.44048081 |
60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.44048081 |
61 | Mitral stenosis (HP:0001718) | 2.43115588 |
62 | Cholelithiasis (HP:0001081) | 2.42367548 |
63 | Gout (HP:0001997) | 2.39806429 |
64 | Cholecystitis (HP:0001082) | 2.35446901 |
65 | Abnormal gallbladder physiology (HP:0012438) | 2.35446901 |
66 | Cerebral edema (HP:0002181) | 2.35155798 |
67 | Irritability (HP:0000737) | 2.32013648 |
68 | Neonatal onset (HP:0003623) | 2.31110352 |
69 | Esophageal varix (HP:0002040) | 2.27391906 |
70 | Cardiovascular calcification (HP:0011915) | 2.25913541 |
71 | Menorrhagia (HP:0000132) | 2.25465861 |
72 | Malnutrition (HP:0004395) | 2.24390438 |
73 | * Gingival bleeding (HP:0000225) | 2.23210520 |
74 | Sensorimotor neuropathy (HP:0007141) | 2.14852971 |
75 | Late onset (HP:0003584) | 2.14270127 |
76 | Pancreatitis (HP:0001733) | 2.11974694 |
77 | * Thrombophlebitis (HP:0004418) | 2.11576121 |
78 | Poikilocytosis (HP:0004447) | 2.11270173 |
79 | Abnormal tarsal ossification (HP:0008369) | 2.11129258 |
80 | Arthropathy (HP:0003040) | 2.10788095 |
81 | Enlarged kidneys (HP:0000105) | 2.10567456 |
82 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07348877 |
83 | * Joint swelling (HP:0001386) | 2.07101570 |
84 | Brushfield spots (HP:0001088) | 2.05409349 |
85 | Abnormality of iron homeostasis (HP:0011031) | 2.05132116 |
86 | Hemorrhage of the eye (HP:0011885) | 2.04224098 |
87 | Vomiting (HP:0002013) | 2.02667033 |
88 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.00745334 |
89 | Increased serum pyruvate (HP:0003542) | 1.99943081 |
90 | Abnormality of the gallbladder (HP:0005264) | 1.99629938 |
91 | Opisthotonus (HP:0002179) | 1.98439547 |
92 | Increased serum ferritin (HP:0003281) | 1.97919016 |
93 | Fair hair (HP:0002286) | 1.97650678 |
94 | Retinal atrophy (HP:0001105) | 1.96093143 |
95 | Nephritis (HP:0000123) | 1.92839198 |
96 | Generalized aminoaciduria (HP:0002909) | 1.91868532 |
97 | * Abnormal delivery (HP:0001787) | 1.91728460 |
98 | Rickets (HP:0002748) | 1.89062468 |
99 | Elevated alkaline phosphatase (HP:0003155) | 1.86764576 |
100 | Hypophosphatemic rickets (HP:0004912) | 1.86147480 |
101 | Abnormality of the Achilles tendon (HP:0005109) | 1.84603737 |
102 | Elevated hepatic transaminases (HP:0002910) | 1.81677889 |
103 | Hyperphosphaturia (HP:0003109) | 1.80144147 |
104 | Glycosuria (HP:0003076) | 1.79522810 |
105 | Abnormality of urine glucose concentration (HP:0011016) | 1.79522810 |
106 | Abnormal cartilage morphology (HP:0002763) | 1.78457296 |
107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77999036 |
108 | Status epilepticus (HP:0002133) | 1.77635518 |
109 | Abnormality of carpal bone ossification (HP:0006257) | 1.76399098 |
110 | Abnormality of proline metabolism (HP:0010907) | 1.76178243 |
111 | Hydroxyprolinuria (HP:0003080) | 1.76178243 |
112 | Alkalosis (HP:0001948) | 1.75910712 |
113 | Renal cortical cysts (HP:0000803) | 1.75882329 |
114 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.75478630 |
115 | * Epistaxis (HP:0000421) | 1.75031964 |
116 | Hyperglycemia (HP:0003074) | 1.73961620 |
117 | Abnormality of glycolysis (HP:0004366) | 1.73913195 |
118 | Pulmonary embolism (HP:0002204) | 1.73311213 |
119 | Abnormality of vitamin metabolism (HP:0100508) | 1.69958421 |
120 | Facial shape deformation (HP:0011334) | 1.62541887 |
121 | Potter facies (HP:0002009) | 1.62541887 |
122 | Reduced antithrombin III activity (HP:0001976) | 1.55958724 |
123 | Bifid scrotum (HP:0000048) | 1.53023841 |
124 | Flat acetabular roof (HP:0003180) | 1.52948296 |
125 | Abnormal urine phosphate concentration (HP:0012599) | 1.50956023 |
126 | Gangrene (HP:0100758) | 1.50555944 |
127 | Proximal tubulopathy (HP:0000114) | 1.50108375 |
128 | Cerebral palsy (HP:0100021) | 1.47774325 |
129 | Increased mean platelet volume (HP:0011877) | 1.42802447 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.74269078 |
2 | ERN1 | 5.19420969 |
3 | FGFR4 | 4.82014506 |
4 | SIK1 | 4.18765299 |
5 | PDK2 | 3.62688562 |
6 | ERBB4 | 3.34372592 |
7 | TAOK3 | 3.16600316 |
8 | INSRR | 3.02562972 |
9 | MAP2K4 | 2.28974194 |
10 | MST1R | 2.13511089 |
11 | MAPK11 | 2.07600618 |
12 | PKN2 | 1.91641654 |
13 | PDGFRA | 1.89137506 |
14 | TRIB3 | 1.83630128 |
15 | TYK2 | 1.82515449 |
16 | PIK3CG | 1.79739607 |
17 | LATS1 | 1.72685660 |
18 | AKT3 | 1.71754728 |
19 | FLT3 | 1.69252596 |
20 | DAPK2 | 1.67186673 |
21 | CDK12 | 1.66429891 |
22 | MAP3K2 | 1.66011649 |
23 | WNK4 | 1.64884972 |
24 | NTRK3 | 1.63783474 |
25 | PTK6 | 1.62059551 |
26 | NEK9 | 1.49003188 |
27 | FGFR1 | 1.46286300 |
28 | ABL2 | 1.39943394 |
29 | JAK2 | 1.34616914 |
30 | TYRO3 | 1.33586189 |
31 | FRK | 1.32591865 |
32 | KDR | 1.30481892 |
33 | FGFR2 | 1.29160575 |
34 | LMTK2 | 1.28853493 |
35 | EPHA3 | 1.22012926 |
36 | ERBB2 | 1.21408939 |
37 | EPHB1 | 1.19054238 |
38 | MAP3K7 | 1.17649592 |
39 | JAK1 | 1.14860852 |
40 | PRKAA2 | 1.09217372 |
41 | GRK6 | 1.08244277 |
42 | NLK | 1.05747857 |
43 | TBK1 | 1.03891737 |
44 | MAP2K3 | 1.00319159 |
45 | PINK1 | 0.96456671 |
46 | EIF2AK1 | 0.95903869 |
47 | MAPK4 | 0.95402514 |
48 | MAP3K14 | 0.95079509 |
49 | SCYL2 | 0.95072789 |
50 | MAP3K10 | 0.91262438 |
51 | MET | 0.89354004 |
52 | FER | 0.89049891 |
53 | PRKCZ | 0.86062482 |
54 | MAP3K12 | 0.82855249 |
55 | MAPK15 | 0.82822005 |
56 | MAP3K3 | 0.81490382 |
57 | MAPK12 | 0.76664884 |
58 | CAMK2G | 0.76532195 |
59 | MAP3K11 | 0.75722892 |
60 | STK38L | 0.75390950 |
61 | CDK6 | 0.74672023 |
62 | TIE1 | 0.73421154 |
63 | RIPK1 | 0.73389499 |
64 | KSR2 | 0.72412269 |
65 | CAMK1D | 0.71147595 |
66 | FGFR3 | 0.70032956 |
67 | EPHA2 | 0.69876671 |
68 | DYRK1B | 0.68694690 |
69 | GSK3A | 0.67059791 |
70 | CSK | 0.66296600 |
71 | PRKAA1 | 0.65287554 |
72 | * PRKACG | 0.64188460 |
73 | CSNK1D | 0.63905358 |
74 | SGK3 | 0.61858076 |
75 | RPS6KB1 | 0.60190032 |
76 | PKN1 | 0.58257734 |
77 | BRSK2 | 0.57049065 |
78 | TGFBR2 | 0.56633837 |
79 | MAP2K6 | 0.56153218 |
80 | MAPKAPK3 | 0.55972767 |
81 | PTK2 | 0.55443920 |
82 | MAPK7 | 0.54545710 |
83 | WNK1 | 0.54319914 |
84 | IKBKE | 0.53560291 |
85 | CSF1R | 0.52907888 |
86 | NEK1 | 0.50667491 |
87 | IRAK3 | 0.49859401 |
88 | PDPK1 | 0.49431284 |
89 | SRC | 0.46817030 |
90 | * CSNK1E | 0.46409217 |
91 | SGK2 | 0.45999838 |
92 | PRKCQ | 0.45478089 |
93 | SGK1 | 0.45244832 |
94 | MAP2K1 | 0.44585821 |
95 | MAP3K5 | 0.44385191 |
96 | PDGFRB | 0.43977197 |
97 | BCR | 0.43902830 |
98 | DDR2 | 0.43575998 |
99 | CSNK2A2 | 0.42638241 |
100 | PRKACA | 0.42543963 |
101 | RET | 0.41986094 |
102 | IGF1R | 0.41670108 |
103 | EEF2K | 0.41604113 |
104 | EIF2AK3 | 0.41432236 |
105 | ACVR1B | 0.40629465 |
106 | MAP3K13 | 0.40403928 |
107 | CSNK1G1 | 0.40361479 |
108 | FGR | 0.40005015 |
109 | GRK1 | 0.39590997 |
110 | RPS6KA3 | 0.39193600 |
111 | MTOR | 0.38666910 |
112 | EPHA4 | 0.38492688 |
113 | PRKCG | 0.38200791 |
114 | EGFR | 0.37321175 |
115 | CDK7 | 0.37101745 |
116 | ICK | 0.36954125 |
117 | CAMKK2 | 0.36843382 |
118 | CDK4 | 0.36773840 |
119 | TAOK2 | 0.36492655 |
120 | ZAP70 | 0.36485492 |
121 | CDC42BPA | 0.35927622 |
122 | MAP3K6 | 0.35717304 |
123 | CDK9 | 0.34065485 |
124 | MAP3K1 | 0.33363974 |
125 | IRAK1 | 0.32776573 |
126 | SGK223 | 0.32227470 |
127 | SGK494 | 0.32227470 |
128 | CAMK4 | 0.32016201 |
129 | PDK1 | 0.27975790 |
130 | PBK | 0.27229132 |
131 | LATS2 | 0.26409099 |
132 | CAMK1G | 0.25437431 |
133 | PRKCA | 0.24570818 |
134 | PIK3CA | 0.23794565 |
135 | PAK3 | 0.23520438 |
136 | BMX | 0.22639515 |
137 | ABL1 | 0.22266928 |
138 | CSNK1G2 | 0.18394821 |
139 | MAPK3 | 0.18270832 |
140 | KIT | 0.16119577 |
141 | CSNK1G3 | 0.15019187 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.54620550 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.80059502 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.47333462 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.23382275 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.13808769 |
6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.00137539 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67804002 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63953787 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62641009 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58269883 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46982746 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.32828466 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.13724139 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10747012 |
15 | Peroxisome_Homo sapiens_hsa04146 | 2.06565032 |
16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.04513138 |
17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.98966882 |
18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88163601 |
19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88063427 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87962691 |
21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87649046 |
22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.83442965 |
23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.82571985 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79589981 |
25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76554454 |
26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70478559 |
27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66926248 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66383268 |
29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61385669 |
30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60906884 |
31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58324655 |
32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57654496 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56439110 |
34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52027129 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50756645 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.48104753 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43809077 |
38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33885187 |
39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32895813 |
40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28893851 |
41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28339202 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23646311 |
43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23186237 |
44 | ABC transporters_Homo sapiens_hsa02010 | 1.21959614 |
45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21706848 |
46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21463857 |
47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19715790 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12290625 |
49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07001030 |
50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02227054 |
51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98608840 |
52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97927225 |
53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97658625 |
54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94174159 |
55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93159270 |
56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91397510 |
57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89895757 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84925587 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80348904 |
60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77637511 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68730477 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65962806 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62761434 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58818169 |
65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55161854 |
66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52523250 |
67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44761500 |
68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44622272 |
69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44179148 |
70 | Prion diseases_Homo sapiens_hsa05020 | 0.42331420 |
71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26733724 |
72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25277899 |
73 | Insulin resistance_Homo sapiens_hsa04931 | 0.24982525 |
74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24784780 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24331363 |
76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19287339 |
77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18967943 |
78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16555832 |
79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11526518 |
80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.07552730 |
81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.04616086 |
82 | Mineral absorption_Homo sapiens_hsa04978 | 0.04559950 |
83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02491036 |
84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2410047 |
85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2320834 |
86 | Pertussis_Homo sapiens_hsa05133 | -0.2198642 |
87 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2192603 |
88 | Amoebiasis_Homo sapiens_hsa05146 | -0.2190130 |
89 | Bladder cancer_Homo sapiens_hsa05219 | -0.1991739 |
90 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1966207 |
91 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1887256 |
92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1881690 |
93 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1856403 |
94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1807881 |
95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1570082 |
96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1556808 |
97 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1551776 |
98 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1548967 |
99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1466778 |
100 | Hepatitis C_Homo sapiens_hsa05160 | -0.1347813 |
101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1297235 |
102 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1169991 |
103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1018000 |
104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0758786 |
105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0681815 |
106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0662562 |
107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0626254 |
108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0594362 |